4. CONMED (CNMD - Get Report) is a medical technology company with an emphasis on surgical devices and equipment for minimally invasive procedures and monitoring. The company's products serve the clinical areas of arthroscopy, powered surgical instruments, electrosurgery, patient care, endosurgery and endoscopic technologies.
The company is scheduled to report its first quarter 2011 results on Apr. 28. Net income is projected to surge to $23.6 million from $7.3 million in the comparable quarter of last year. On a per share basis, earnings are seen at 31 cents compared to 25 cents. Total revenue is forecasted to increase 2.8 to $181.3 million from $176.4 million, according to analysts polled by Bloomberg.
During Feb, the company announced that its CONMED Linvatec business unit launched five new medical devices in its Sports Medicine and Capital product lines. Furthermore, the company expects its 2011 revenue to be in the range of $745-$755 million, and earnings between $1.40 and $1.50 per share.Of the six analysts covering the stock, 33% recommend it a buy, while the remaining rate a hold. There are no sell ratings on the stock. On average, analysts expect an upside of 18.7% to $33.5 in value from current levels.